Clinical Trial Update: Observational Study of VYKAT™ XR in Patients With Prader-Willi Syndrome

View source ↗

Summary

An observational study evaluating VYKAT XR in patients with Prader-Willi Syndrome, sponsored by Soleno Therapeutics, Inc., currently enrolling by invitation.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prader-willi Syndrome

Drugs mentioned

• VYKAT XR (Diazoxide choline)

Snippet

Sponsor: Soleno Therapeutics, Inc. | Conditions: Prader-Willi Syndrome | Status: ENROLLING_BY_INVITATION